Could a DNA-Clearing enzyme help fight sepsis? new trial launches
NCT ID NCT05453695
First seen Mar 16, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This early-stage study tests whether a drug called DNase I is safe and feasible for ICU patients with sepsis. Sepsis is a life-threatening response to infection that can cause organ failure. The trial will enroll 36 adults and monitor how many complete the treatment and how their organ function changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hamilton Health Sciences
RECRUITINGHamilton, Ontario, L8L 0A4, Canada
Contact
Conditions
Explore the condition pages connected to this study.